Based on Zhang et al.’s report [2], we suggest that aloperine might suppress the activation of Akt pathway and the downstream Bcl-2 expression to modulate cellular apoptosis in human thyroid cancers. The gene discussed is BCL2; the disease is thyroid gland carcinoma.